Company:  KERYX BIOPHARMACEUTICALS ... (KERX)
Form Type:  8-K
Filing Date:  2/29/2012 
CIK:  0001114220 
Address:  750 LEXINGTON AVENUE
. 
City, State, Zip:  NEW YORK, New York 10022 
Telephone:  212-531-5965 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$8.03   		Change: 
0.15 (1.90%)  
Trade Time: 
May 23   		Market Cap: 
$656.20M
Description of Business
Register for a Free Trial and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02. Results of Operations and Financial Condition.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURE
    INDEX TO EXHIBITS
  EXHIBIT 99.1
    INCOME STATEMENT
    BALANCE SHEET
© 1995-2013 EDGAR Online, Inc. All rights reserved • NASDAQ: EDGR • Solutions for Corporations • Terms of Use • Privacy Statement